Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5875_Библиотеки_им_академика_М_И_Перельмана
.pdf
https://t.me/med1917
44
Chen, Z., Han, C., Gao, M., Kandukuri, S. Y., & Zhou, K. (2022). A review on qualication
Handbook of 3D Printing in Pharmaceutics
and certication for metal additive manufacturing. Virtual and Physical Prototyping,
17(2), 382– 405.
Devi, A., Mathiyazhagan, K., & Kumar, H. (2021). Additive manufacturing in supply
chain management: A systematic review. Advances in Manufacturing and Industrial
Engineering: Select Proceedings of ICAPIE 2019, Delhi, India, December 20– 21, 2019,
455– 464.
Divakaran, N., Das, J. P., Pv, A. K., Mohanty, S., Ramadoss, A., & Nayak, S. K. (2022).
Comprehensive review on various additive manufacturing techniques and its implementation in electronic devices. Journal of Manufacturing Systems, 62, 477– 502.
Gackowski, B. M., Phua, H., Sharma, M., & Idapalapati, S. (2022). Hybrid additive manu-
facturing of polymer composites reinforced with buckypapers and short carbon bres.
Composites Part A: Applied Science and Manufacturing, 154, 106794. https:// doi.org/
10.1016/ j.comp osit esa.2021.106 794
Guo, N., & Leu, M. C. (2013). Additive manufacturing: technology, applications and research
needs. Frontiers of Mechanical Engineering, 8(3), 215– 243. https:// doi.org/ 10.1007/ s11
465- 013- 0248- 8
Gutowski, T., Jiang, S., Cooper, D., Corman, G., Hausmann, M., Manson, J. A., Schudeleit,
T., Wegener, K., Sabelle, M., & Ramos- Grez, J. (2017). Note on the rate and energy
efciency limits for additive manufacturing. Journal of Industrial Ecology, 21(S1),
S69– S79.
Herderick, E. D. (2015). Progress in additive manufacturing. JOM, 67(3), 580– 581.
Höller, C., Karanovic, S., Wiltsche, M., & Klug, A. (2022). Value creation through insour-
cing – Additive manufacturing as efcient in- house production technology. Procedia
CIRP, 107, 1391– 1396. https:// doi.org/ 10.1016/ j.pro cir.2022.05.163
Satair (2020). Five challenges of additive manufacturing in the aviation industry Technology,
Industry trends, Mar 18. https:// blog.sat air.com/ ve- cha llen ges- addit ive- manufa
ctur ing.
Jadhav, A., & Jadhav, V. S. (2022). A review on 3D printing: An additive manufacturing
technology. Materials Today: Proceedings, 62, 2094– 2099. https:// doi.org/ 10.1016/
j.matpr.2022.02.558
Jamróz, W., Kurek, M., Łyszczarz, E., Szafraniec, J., Knapik- Kowalczuk, J., Syrek, K.,
Paluch, M., & Jachowicz, R. (2017). 3D printed orodispersible lms with Aripiprazole.
International Journal of Pharmaceutics, 533(2), 413– 420. https:// doi.org/ 10.1016/ j.ijph
arm.2017.05.052
Khaled, S. A., Burley, J. C., Alexander, M. R., & Roberts, C. J. (2014). Desktop 3D printing of
controlled release pharmaceutical bilayer tablets. International Journal of Pharmaceutics,
461(1), 105– 111. https:// doi.org/ 10.1016/ j.ijph arm.2013.11.021
Khaled, S. A., Burley, J. C., Alexander, M. R., Yang, J., & Roberts, C. J. (2015). 3D printing
of ve- in- one dose combination polypill with dened immediate and sustained release
proles. Journal of Controlled Release, 217, 308– 314. https:// doi.org/ 10.1016/ j.jcon
rel.2015.09.028
Kietzmann, J., Pitt, L., & Berthon, P. (2015). Disruptions, decisions, and destinations: Enter
the age of 3- D printing and additive manufacturing. Business Horizons, 58(2), 209– 215.
Kulkarni, P., Kumar, A., Chate, G., & Dandannavar, P. (2021). Elements of additive manu-
facturing technology adoption in small- and medium- sized companies. Innovation &
Management Review, 18(4), 400– 416.
Lakshmanan, R., Nyamekye, P., Virolainen, V.- M., & Piili, H. (2023). The convergence of lean
management and additive manufacturing: Case of manufacturing industries. Cleaner
Engineering and Technology, 13(2), 100620.
https://t.me/med1917
Modified Additive Manufacturing Processes
Leary, M. (2020). Chapter 13 – Binder jetting. In M. Leary (Ed.), Design for Additive
45
Manufacturing (pp. 335– 339). Elsevier. https:// doi.org/ 10.1016/ B978- 0- 12- 816
721- 2.00013- 0
Li, Q., Wen, H., Jia, D., Guan, X., Pan, H., Yang, Y., Yu, S., Zhu, Z., Xiang, R., & Pan, W.
(2017). Preparation and investigation of controlled- release glipizide novel oral device
with three- dimensional printing. International Journal of Pharmaceutics, 525(1), 5– 11.
https:// doi.org/ 10.1016/ j.ijph arm.2017.03.066
Lim, S. H., Kathuria, H., Tan, J. J. Y., & Kang, L. (2018). 3D printed drug delivery and testing
systems – a passing fad or the future? Advanced Drug Delivery Reviews, 132, 139– 168.
https:// doi.org/ 10.1016/ j.addr.2018.05.006
Liravi, F., & Toyserkani, E. (2018). A hybrid additive manufacturing method for the fabrica-
tion of silicone bio- structures: 3D printing optimization and surface characterization.
Materials & Design, 138, 46– 61. https:// doi.org/ 10.1016/ j.mat des.2017.10.051
Lu, B., Li, D., & Tian, X. (2015). Development trends in additive manufacturing and 3D
printing. Engineering, 1(1), 085– 089. https:// doi.org/ 10.15302/ J- ENG- 2015 012
Lu, X., Lee, Y., Yang, S., Hao, Y., Evans, J. R. G., & Parini, C. G. (2010). Solvent- based paste
extrusion solid freeforming. Journal of the European Ceramic Society, 30(1), 1– 10.
https:// doi.org/ 10.1016/ j.jeurc eram soc.2009.07.019
Ma, J., Li, Z., Zhao, Z.- L., & Xie, Y. M. (2021). Creating novel furniture through topology opti-
mization and advanced manufacturing. Rapid Prototyping Journal, 27(9), 1749– 1758.
Malshe, H., Nagarajan, H., Pan, Y., & Haapala, K. (2015). Prole of sustainability in addi-
tive manufacturing and environmental assessment of a novel stereolithography process.
ASME 2015 International Manufacturing Science and Engineering Conference, June
8– 12, 2015, Charlotte, North Carolina, USA, Conference Sponsors: Manufacturing
Engineering Division. Volume 2: Materials; Biomanufacturing; Properties, Applications
and Systems; Sustainable Manufacturing. ISBN: 978- 0- 7918- 5683- 3
Mançanares, C. G., de Senzi Zancul, E., & Miguel, P. A. C. (2015). Sustainable manufacturing
strategies: a literature review on additive manufacturing approach. Product: Management
and Development, 13(1), 47– 56.
Mehrpouya, M., Vosooghnia, A., Dehghanghadikolaei, A., & Fotovvati, B. (2021). The
benets of additive manufacturing for sustainable design and production. In Sustainable
Manufacturing (pp. 29– 59). Elsevier.
Mohammed, A., Elshaer, A., Sareh, P., Elsayed, M., & Hassanin, H. (2020). Additive
manufacturing technologies for drug delivery applications. International Journal of
Pharmaceutics, 580, 119245. https:// doi.org/ 10.1016/ j.ijph arm.2020.119 245
Mostafaei, A., Elliott, A. M., Barnes, J. E., Li, F., Tan, W., Cramer, C. L., Nandwana, P., &
Chmielus, M. (2021). Binder jet 3D printing – Process parameters, materials, properties,
modeling, and challenges. Progress in Materials Science, 119, 100707. https:// doi.org/
10.1016/ j.pmat sci.2020.100 707
Mwema, F. M., & Akinlabi, E. T. (2020). Basics of fused deposition modelling (FDM). In F.
M. Mwema & E. T. Akinlabi (Eds.), Fused Deposition Modeling: Strategies for Quality
Enhancement (pp. 1– 15). Springer International. https:// doi.org/ 10.1007/ 978- 3- 030-
48259- 6_ 1
Ngo, T. D., Kashani, A., Imbalzano, G., Nguyen, K. T. Q., & Hui, D. (2018). Additive manu-
facturing (3D printing): A review of materials, methods, applications and challenges.
Composites Part B: Engineering, 143, 172– 196.
Panraksa, P., Udomsom, S., Rachtanapun, P., Chittasupho, C., Ruksiriwanich, W., & Jantrawut,
P. (2020). Hydroxypropyl methylcellulose E15: A hydrophilic polymer for fabrication of
orodispersible lm using syringe extrusion 3D printer. Polymers, 12: 2666. https:// doi.
org/ 10.3390/ polym1 2112 666
https://t.me/med1917
46
Pignatelli, F., & Percoco, G. (2022). An application- and market- oriented review on large
Handbook of 3D Printing in Pharmaceutics
format additive manufacturing, focusing on polymer pellet- based 3D printing. Progress
in Additive Manufacturing, 7(6), 1363– 1377.
Prashanth, K. G., & Wang, Z. (2020). Additive manufacturing: Alloy design and process
innovations. Materials, 13(3), 542.
Rahman, Z., Barakh Ali, S. F., Ozkan, T., Charoo, N. A., Reddy, I. K., & Khan, M. A. (2018).
Additive manufacturing with 3D printing: Progress from bench to bedside. AAPS
Journal, 20(6), 101. https:// doi.org/ 10.1208/ s12 248- 018- 0225- 6
Raja, S., & John Rajan, A. (2023). Challenges and opportunities in additive manufacturing
polymer technology: A review based on optimization perspective. Advances in Polymer
Technology, 2023, 8639185. https:// doi.org/ 10.1155/ 2023/ 8639 185
Rommel, S., & Fischer, A. (2013). Additive manufacturing – A growing possibility to lighten
the burden of spare parts supply. In G. L. Kovács & Kochan, D. (Eds), Digital Product and
Process Development Systems. NEW PROLAMAT 2013. IFIP Advances in Information
and Communication Technology, vol 411. Springer, Berlin, Heidelberg. https:// doi.org/
10.1007/ 978- 3- 642- 41329- 2_ 13
Sai Saran, O., Prudhvidhar Reddy, A., Chaturya, L., & Pavan Kumar, M. (2022). 3D printing
of composite materials: A short review. Materials Today: Proceedings, 64, 615– 619.
https:// doi.org/ 10.1016/ j.matpr.2022.05.144
Salmi, M. (2021). Additive manufacturing processes in medical applications. Materials (Basel,
Switzerland), 14(1). https:// doi.org/ 10.3390/ ma1 4010 191
Schuh, G., Kreysa, J., & Orilski, S. (2009). Roadmap “Hybride Produktion”: Wie 1+ 1= 3-
Effekte in der Produktion maximiert werden können. Fraunhofer IPT, 104(5). https://
doi.org/ 10.3139/ 104.110 072
Sealy, M. P., Madireddy, G., Williams, R. E., Rao, P., & Toursangsaraki, M. (2018). Hybrid
processes in additive manufacturing. Journal of Manufacturing Science and Engineering,
140(6). https:// doi.org/ 10.1115/ 1.4038 644
Sen, K., West, T. G., & Chaudhuri, B. (2023). History and present scenario of additive
manufacturing in pharmaceuticals. In S. Banerjee (Ed.), Additive Manufacturing in
Pharmaceuticals (pp. 1– 44). Springer Nature Singapore. https:// doi.org/ 10.1007/ 978-
981- 99- 2404- 2_ 1
Sing, S. L., Tey, C. F., Tan, J. H. K., Huang, S., & Yeong, W. Y. (2020). 2– 3D printing of
metals in rapid prototyping of biomaterials: Techniques in additive manufacturing. In
R. Narayan (Ed.), Rapid Prototyping of Biomaterials (Second Edition) (pp. 17– 40).
Woodhead Publishing. https:// doi.org/ 10.1016/ B978- 0- 08- 102 663- 2.00002- 2
Srivastava, M., & Rathee, S. (2021). Additive manufacturing: recent trends, applications
and future outlooks. Progress in Additive Manufacturing, 7, 261– 287. https:// doi.org/
10.1007/ s40 964- 021- 00229- 8
Svetlizky, D., Das, M., Zheng, B., Vyatskikh, A. L., Bose, S., Bandyopadhyay, A., Schoenung,
J. M., Lavernia, E. J., & Eliaz, N. (2021). Directed energy deposition (DED) additive
manufacturing: Physical characteristics, defects, challenges and applications. Materials
Today, 49, 271– 295. https:// doi.org/ 10.1016/ j.mat tod.2021.03.020
Tan, D., Nokhodchi, A., & Maniruzzaman, M. (2019). 3D and 4D printing technolo-
gies: Innovative process engineering and smart additive manufacturing. In Mohammed
Maniruzzaman (ed), 3D and 4D Printing in Biomedical Applications (pp. 25– 52). Wiley.
https:// doi.org/ 10.1002/ 978352 7813 704.ch2
Tan, H. W., & Choong, Y. Y. C. (2021). Additive manufacturing in COVID- 19: recognising the
challenges and driving for assurance. Virtual and Physical Prototyping, 16(4), 498– 503.
Trivedi, M., Jee, J., Silva, S., Blomgren, C., Pontinha, V. M., Dixon, D. L., Van Tassel,
B., Bortner, M. J., Williams, C., & Gilmer, E. (2018). Additive manufacturing of
https://t.me/med1917
Modified Additive Manufacturing Processes
47
pharmaceuticals for precision medicine applications: A review of the promises and perils
in implementation. Additive Manufacturing, 23, 319– 328.
Vaz, V. M., & Kumar, L. (2021). 3D printing as a promising tool in personalized medicine.
AAPS PharmSciTech, 22(1), 49. https:// doi.org/ 10.1208/ s12 249- 020- 01905- 8
Vranić, A., Bogojevic, N., Ćirić Kostić, S., Croccolo, D., & Olmi, G. (2017). Advantages and
drawbacks of additive manufacturing. IMK- 14 - Istraživanje i razvoj, 23(2), 57– 62.
DOI: 10.5937/ IMK1702057V
Weisman, J. A., Ballard, D. H., Jammalamadaka, U., Tappa, K., Sumerel, J., D’Agostino, H.
B., Mills, D. K., & Woodard, P. K. (2019). 3D printed antibiotic and chemotherapeutic
eluting catheters for potential use in interventional radiology: In vitro proof of concept
study. Academic Radiology, 26(2), 270– 274. https:// doi.org/ 10.1016/ j.acra.2018.03.022
Wilts, E. M., Ma, D., Bai, Y., Williams, C. B., & Long, T. E. (2019). Comparison of linear and
4- arm star poly (vinyl pyrrolidone) for aqueous binder jetting additive manufacturing of
personalized dosage tablets. ACS Applied Materials & Interfaces, 11(27), 23938– 23947.
Zhang, J., Feng, X., Patil, H., Tiwari, R. V., & Repka, M. A. (2017). Coupling 3D printing
with hot- melt extrusion to produce controlled- release tablets. International Journal of
Pharmaceutics, 519(1), 186– 197. https:// doi.org/ 10.1016/ j.ijph arm.2016.12.049
Zhang, J., Hu, Q., Wang, S., Tao, J., & Gou, M. (2020). Digital light processing based three-
dimensional printing for medical applications. International Journal of Bioprinting,
6(1), 242. https:// doi.org/ 10.18063/ ijb.v6i1.242
Zhang, J., Vo, A. Q., Feng, X., Bandari, S., & Repka, M. A. (2018). Pharmaceutical additive
manufacturing: A novel tool for complex and personalized drug delivery systems. AAPS
PharmSciTech, 19(8), 3388– 3402. https:// doi.org/ 10.1208/ s12 249- 018- 1097- x
Zhang, Y., Jarosinski, W., Jung, Y.- G., & Zhang, J. (2018). 2 – Additive manufacturing processes
and equipment. In J. Zhang & Y.- G. Jung (Eds.), Additive Manufacturing (pp. 39– 51).
Butterworth- Heinemann. https:// doi.org/ 10.1016/ B978- 0- 12- 812 155- 9.00002- 5
https://t.me/med1917
https://t.me/med1917
Section II
Quality Characteristics’
Challenge in 3D Printing
of Pharmaceutical Products
https://t.me/med1917
https://t.me/med1917
Navigating the
3
Terrain of 3DP for
Pharmaceutical Products
Quality Conundrums and
Solutions
Kanaka Durga Devi Nelluri, Sk. Abdul Rahaman,
Vijaya Lakshmi Marella, Kakani Anil Kumar, and
Kondabrolu Naga Bhargavi
3.1 INTRODUCTION
With the arrival of three-dimensional printing (3DP) technology, the pharmaceutical
production industry has undergone tremendous change. This novel approach has
transformed conventional medication manufacturing by enabling the development
of detailed and personalized dosage forms, as well as highly accurate and exible
medical equipment (Awad et al., 2018). As the potential for 3DP to revolutionize the
pharmaceutical sector grows, new opportunities and obstacles must be thoroughly
investigated (Alhnan et al., 2016). The discussion, titled “Navigating the Terrain of
3DP for Pharmaceutical Products: Quality Conundrums and Solutions,” focuses on
the delicate connection between the cutting- edge world of 3DP and the strict needs
of pharmaceutical quality assurance. As this eld evolves, it is critical to gain a better
knowledge of the issues it brings and the solutions it necessitates (Alhnan et al.,
2016). The goal of this investigation is not only to shed light on existing obstacles, but
also to nd novel solutions to overcome them, ensuring the quality and effectiveness
of pharmaceutical goods created with 3DP. In this context, the introduction serves
as a jumping- off point for a thorough examination of the landscape. It sets the scene
for an investigation of the complications that lie ahead by discussing the relevance of
3DP’s impact on pharmaceuticals. The introduction emphasizes 3DP’s critical role in
revolutionizing the pharmaceutical sector, as well as how it has overcome traditional
manufacturing limits. Yet it recognizes the complications that come with this technological transformation, particularly in terms of preserving the high quality, safety, and
effectiveness that pharmaceutical products demand.
This discussion will go into the numerous elements of this topic in the next parts,
including the challenges that occur in assuring the quality of 3D- printed medications.
51DOI: 10.1201/9781003439509-5
https://t.me/med1917
52
Handbook of 3D Printing in Pharmaceutics
This inquiry intends to not only identify the impediments but also propose proactive
solutions that can lead the pharmaceutical sector in exploiting the full potential of
3DP through a complete investigation of these quality conundrums (Basit et al.,
2022; Sen et al., 2021). Each component, from material selection and process val -
idation to testing procedures and regulatory compliance, is a vital jigsaw piece that
must be solved in order to effectively utilize the transformative power of 3DP in
pharmaceuticals (Ho et al., 2020; Mostafaei et al., 2021; Sankar et al., 2017).
3.2 THE PROMISE AND PERILS OF 3DP IN PHARMACEUTICALS
By applying layers one at a time, 3DP, sometimes referred to as additive manufacturing, enables the accurate creation of complex shapes (Gupta et al., 2021; Goyanes
et al., 2017). This technology has the ability to completely alter drug delivery and formulation in the pharmaceutical sector. A few of the promises that 3DP holds include
personalized medicines, complex drug- release patterns, and customizable dose forms
(Pérez- Sanpablo et al., 2021; Oblom et al., 2019).The convergence of 3DP and
pharmaceuticals is a captivating prospect, heralding a new era of tailored therapeutic
interventions. Personalized medicine, a cornerstone of modern healthcare, becomes
even more achievable with 3DP (Chatzitaki et al., 2021). Through the precise deposition of pharmaceutical ingredients, patient- specic dosage forms can be fabricated,
aligning drug delivery with an individual’s unique needs. This not only enhances
treatment efcacy but also minimizes potential side effects, effectively revolutionizing the paradigm of medication.
Furthermore, the potential for 3DP to engineer complex drug- release patterns
offers unprecedented control over pharmacokinetics. Tailoring the release prole of
a drug can be crucial in optimizing therapeutic outcomes, especially for conditions
requiring sustained or targeted delivery (Gioumouxouzis et al., 2020; Genina et al.,
2017). The technology enables the creation of intricate structures within dosage
forms, allowing drugs to be released in specic sequences or at varying rates. This
opens doors to innovative treatments, such as combination therapies within a single
dosage form or the synchronization of multiple drug administrations. Customizable
dose forms represent another frontier unlocked by 3DP. Traditional dosage forms
often necessitate compromises between mass production efciency and patient-
specic requirements. But due to 3DP’s inherent adaptability, medications can be
precisely tailored to individual patient needs (Goyanes et al., 2017). This is particularly promising in paediatrics, geriatrics, and cases where conventional dosage forms
present challenges. However, it is not simple to incorporate 3DP into the pharmaceutical industry. Assurance of the uniformity and quality of 3D- printed pharmaceutical
items is one of the main challenges. 3DP must follow the regulatory standards and
quality assurance procedures that have been developed for traditional manufacturing
techniques. The quality, stability, and performance of the nished product are also
substantially impacted by factors including material choice, printing conditions, and post-
processing procedures. As we navigate these promises, it is essential to acknowledge
the perils that accompany such transformative technology. Regulatory frameworks
must adapt to address the unique aspects of 3DP, ensuring patient safety without stifling innovation (Khaled et al., 2017). Material selection becomes an intricate dance
https://t.me/med1917
Navigating the Terrain of 3DP
53
FIGURE 3.1 Pharmaceutical applications of 3DP.
between compatibility, stability, and regulatory compliance. Printing conditions and
parameters introduce a layer of complexity to manufacturing processes, necessitating
meticulous optimization and validation efforts (Krause et al., 2021).
In summary, the intersection of 3DP and pharmaceuticals unveils remarkable
promises that have the potential to redene healthcare. From personalized medicine
to intricate drug- release strategies, the possibilities are captivating. Pharmaceutical
applications of 3DP were shown in Figure 3.1. Yet, these promises are entwined with
challenges that demand thoughtful solutions (Liang et al., 2018; Li et al., 2018). By
embarking on this journey with cautious optimism, the pharmaceutical industry can
unlock a future where medications are as unique as the individuals they treat.
3.3 METHODS OF 3DP OF PHARMACEUTICAL PRODUCTS
Table 3.1 shows the different types of 3DP processes with their working procedure
and their applications in pharmaceuticals.
3.4 QUALITY CONUNDRUMS IN 3D- PRINTED
PHARMACEUTICALS
The choice of materials for 3DP emerges as a critical quality conundrum. Unlike
conventional pharmaceutical materials, the spectrum of materials used in 3DP
ranges from polymers to metals, introducing complexity to compatibility and stability assessments (Norman et al., 2017; Mostafaei et al., 2021). The solution lies
in innovative material development, crafting materials specically tailored to the
Соседние файлы в папке Библиотека им академика М.И. Перельмана